Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
26 studies found for:    "Diabetic Ketoacidosis"
Show Display Options
RSS Create an RSS feed from your search for:
"Diabetic Ketoacidosis"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
Basal Insulin in the Management of Patients With Diabetic Ketoacidosis (DKA)
Condition: Diabetic Ketoacidosis
Interventions: Drug: insulin glargine+ glulisine;   Drug: NPH + Regular insulin
2 Completed Subcutaneous Aspart Insulin to Treat Diabetic Ketoacidosis (DKA) and Beta-Hydroxybutyrate Testing in DKA
Condition: Diabetic Ketoacidosis
Intervention: Drug: Insulin (Aspart Insulin [Novolog], Regular Insulin)
3 Completed
Has Results
Cerebral Edema in Pediatric Diabetic Ketoacidosis
Condition: Diabetic Ketoacidosis
Intervention: Other: intravenous fluid treatment
4 Active, not recruiting Diabetic Ketoacidosis: Brain Morphology and Cognition
Condition: Diabetic Ketoacidosis
Intervention:
5 Unknown  Use of Insulin Glargine to Treat Diabetic Ketoacidosis
Condition: Diabetic Ketoacidosis
Interventions: Drug: glargine;   Drug: saline
6 Recruiting Early Subcutaneous Insulin Glargine Plus Standard of Care for Treatment of Diabetic Ketoacidosis
Condition: Diabetic Ketoacidosis
Interventions: Other: Early administration of subcutaneous insulin glargine dose;   Other: IV insulin infusion;   Drug: IV fluid repletion
7 Completed Effectiveness of Subcutaneous Glargine On The Time To Closure of The Anion Gap in Patients Presenting to the Emergency Department With Diabetic Keto-acidosis
Condition: Diabetic Ketoacidosis
Interventions: Drug: Insulin Glargine;   Drug: Regular Insulin
8 Recruiting Randomized Control Trial of Fluid Therapy for Pediatric Diabetic Ketoacidosis
Conditions: Cerebral Edema;   Diabetic Ketoacidosis
Interventions: Other: Intravenous fluid;   Other: intravenous fluid
9 Unknown  DKA Optic Ultrasound
Conditions: Diabetic Ketoacidosis;   Uncontrolled Type 1 Diabetes Mellitus
Intervention:
10 Not yet recruiting Early Administration of Long-acting Insulin Treatment of Diabetic Ketoacidosis in Pediatric New-onset Type 1 Diabetes
Conditions: Diabetes Mellitus, Type 1;   Diabetic Ketoacidosis
Interventions: Drug: Glargine;   Drug: IV insulin;   Other: Electrolyte Correction;   Other: Correction of Fluid Loss
11 Unknown  Compliance With American Diabetes Association Treatment Guidelines for Adult Ketoacidosis
Condition: Diabetic Ketoacidosis
Intervention:
12 Recruiting Allogeneic Umbilical Cord Mesenchymal Stem Cell Transplantation for Type 1 Diabetes With Diabetic Ketoacidosis
Condition: Ketoacidosis, Diabetic
Intervention: Procedure: umbilical cord mesenchymal stem cell
13 Completed Fluid Resuscitation for Pediatric Diabetic Ketoacidosis
Condition: Diabetes
Interventions: Other: slow fluid rate;   Other: fast fluid rate
14 Recruiting Fluid Kinetics in Patients With Diabetic Ketoacidosis
Condition: Diabetes
Intervention: Drug: SodiumChloride
15 Recruiting Diabetic Ketoacidosis and Its Impact on the Brain
Condition: Diabetes Mellitus
Intervention:
16 Recruiting Evaluation of a Non-invasive Brain Compliance Measurement Device
Conditions: Diabetes;   Diabetic Ketoacidosis
Interventions: Other: this is not an intervention study;   Device: MRI
17 Suspended Anti-IL-1 Treatment in Children Diabetic Keto-Acidosis (DKA) at Diagnosis of Type 1 Diabetes
Condition: Type I Diabetes
Interventions: Drug: Anakinra;   Other: Placebo Comparator
18 Recruiting Evaluation of the Cerebral Edema in Children Having Diabetic Ketoacidosis
Condition: Cerebral Edema
Intervention: Other: Ultrasonic Measurement
19 Active, not recruiting Study on Incidence of Diabetic Ketoacidosis Among Participants With Type 2 Diabetes Mellitus Treated With Sodium-glucose Co-transporter 2 (SGLT2) Inhibitors or Other Antihyperglycemic Agents
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: No Intervention
20 Completed Combination of Sulfonylureas and Insulin Glargine Outpatient Therapy for Unstable Diabetes and Impending DKA
Condition: Type 2 Diabetes
Interventions: Drug: Glipizide;   Drug: Glipizide and Glargine

   Previous Page Studies Shown (1-20) Next Page (21-26) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.